Business News
INKSURE AND AUTHENTIFORM ANNOUNCE ASSIGNMENT OF PATENT PORTFOLIO
Wednesday 30. January 2008 - Sublicense for Humanitarian Purposes Granted to Global Vaccines
InkSure Technologies Inc. (OTC Bulletin Board: INKS – News), a leading provider of covert machine-readable security solutions (“CMRT”) for the detection of counterfeiting, fraud and diversion, and AuthentiForm Technologies, L.L.C., a developer of innovative authentication and item-level identification technologies, today announced that they have entered into an assignment agreement by which InkSure has acquired AuthentiForms entire intellectual property portfolio of enhanced product-authentication technology.
The AuthentiForm portfolio includes methods to establish authenticity and identify products at the item level by encoding high information-density, invisible, and essentially tamper-proof signatures within a products formulation, on its surface, or through incorporation into its packaging. AuthentiForm technology enables dynamic codes without substantially changing the chemical composition of a product or its components, which makes the AuthentiForm technology particularly attractive for use with pharmaceutical products.
“We have been impressed with AuthentiForms developments for some time and believe that its enhanced product identification techniques will be very compatible with a new InkSure product line in development,” commented Yaron Meerfeld, Chief Operating Officer of InkSure Technologies Inc. “Brand owners want more than authentication products: they are looking for solutions,” added Mr. Meerfeld. “We believe that this addition to our authentication and track-and-trace capabilities will offer new and exciting solutions to our portfolio.”
“InkSure emerged as the assignee of choice because of its forward-thinking stance on the technologys value,” stated AuthentiForms Managing Owner Tom Mercolino.
As a further condition of the assignment agreement, InkSure has granted back to AuthentiForm the right to license its portfolio for humanitarian uses. AuthentiForm will sublicense some of the technologys humanitarian-use rights to Global Vaccines, Inc. (GVI), a non-profit vaccine company. “InkSure has shown its commitment to reducing the insidious effects of counterfeit products by agreeing that AuthentiForm may retain humanitarian-use rights,” Mercolino said. “I am delighted that Global Vaccines will be able to use AuthentiForm to protect its vaccines for people in the developing world.”
“The AuthentiForm technology will help Global fulfill its mission of delivering safe and effective vaccines to the developing world,” said GVIs Director of Development Jake Wiltshire. “Because it will ensure that people in developing countries are not receiving counterfeit products, its a wonderful addition to our existing vaccine portfolio.”